144 related articles for article (PubMed ID: 8622623)
1. 5-Carboxamido-tryptamine, CP-122,288 and dihydroergotamine but not sumatriptan, CP-93,129, and serotonin-5-O-carboxymethyl-glycyl -tyrosinamide block dural plasma protein extravasation in knockout mice that lack 5-hydroxytryptamine1B receptors.
Yu XJ; Waeber C; Castanon N; Scearce K; Hen R; Macor JE; Chauveau J; Moskowitz MA
Mol Pharmacol; 1996 May; 49(5):761-5. PubMed ID: 8622623
[TBL] [Abstract][Full Text] [Related]
2. The 5-HT1D receptor antagonist GR-127,935 prevents inhibitory effects of sumatriptan but not CP-122,288 and 5-CT on neurogenic plasma extravasation within guinea pig dura mater.
Yu XJ; Cutrer FM; Moskowitz MA; Waeber C
Neuropharmacology; 1997 Jan; 36(1):83-91. PubMed ID: 9144644
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of 5-HT1B/1D receptor agonists on neurogenic dural plasma extravasation and vasodilation in anaesthetized rats.
Shepherd SL; Williamson DJ; Beer MS; Hill RG; Hargreaves RJ
Neuropharmacology; 1997; 36(4-5):525-33. PubMed ID: 9225277
[TBL] [Abstract][Full Text] [Related]
4. The in vivo pharmacological profile of a 5-HT1 receptor agonist, CP-122,288, a selective inhibitor of neurogenic inflammation.
Gupta P; Brown D; Butler P; Ellis P; Grayson KL; Land GC; Macor JE; Robson SF; Wythes MJ; Shepperson NB
Br J Pharmacol; 1995 Nov; 116(5):2385-90. PubMed ID: 8581273
[TBL] [Abstract][Full Text] [Related]
5. Time-dependent blockade of neurogenic plasma extravasation in dura mater by 5-HT1B/D agonists and endopeptidase 24.11.
Huang Z; Byun B; Matsubara T; Moskowitz MA
Br J Pharmacol; 1993 Feb; 108(2):331-5. PubMed ID: 8383561
[TBL] [Abstract][Full Text] [Related]
6. The in vivo pharmacological profile of eletriptan (UK-116,044): a potent and novel 5-HT(1B/1D) receptor agonist.
Gupta P; Butler P; Shepperson NB; McHarg A
Eur J Pharmacol; 2000 Jun; 398(1):73-81. PubMed ID: 10856450
[TBL] [Abstract][Full Text] [Related]
7. Evidence for 5-HT1B/1D receptors mediating the antimigraine effect of sumatriptan and dihydroergotamine.
Buzzi MG; Moskowitz MA
Cephalalgia; 1991 Sep; 11(4):165-8. PubMed ID: 1660351
[TBL] [Abstract][Full Text] [Related]
8. [3H]sumatriptan labels both 5-HT1D and 5-HT1F receptor binding sites in the guinea pig brain: an autoradiographic study.
Waeber C; Moskowitz MA
Naunyn Schmiedebergs Arch Pharmacol; 1995 Sep; 352(3):263-75. PubMed ID: 8584041
[TBL] [Abstract][Full Text] [Related]
9. CP-93,129, a potent and selective 5-HT1B receptor agonist blocks neurogenic plasma extravasation within rat but not guinea-pig dura mater.
Matsubara T; Moskowitz MA; Byun B
Br J Pharmacol; 1991 Sep; 104(1):3-4. PubMed ID: 1664765
[TBL] [Abstract][Full Text] [Related]
10. The pre- and postjunctional activity of CP-122,288, a conformationally restricted analogue of sumatriptan.
Beattie DT; Connor HE
Eur J Pharmacol; 1995 Apr; 276(3):271-6. PubMed ID: 7601213
[TBL] [Abstract][Full Text] [Related]
11. Further characterization of the putative 5-HT receptor which mediates blockade of neurogenic plasma extravasation in rat dura mater.
Buzzi MG; Moskowitz MA; Peroutka SJ; Byun B
Br J Pharmacol; 1991 Jun; 103(2):1421-8. PubMed ID: 1653072
[TBL] [Abstract][Full Text] [Related]
12. A comparative autoradiographic study of 5-HT1D binding sites in human and guinea-pig brain using different radioligands.
Bruinvels AT; Landwehrmeyer B; Probst A; Palacios JM; Hoyer D
Brain Res Mol Brain Res; 1994 Jan; 21(1-2):19-29. PubMed ID: 8164519
[TBL] [Abstract][Full Text] [Related]
13. CP-93,129, sumatriptan, dihydroergotamine block c-fos expression within rat trigeminal nucleus caudalis caused by chemical stimulation of the meninges.
Nozaki K; Moskowitz MA; Boccalini P
Br J Pharmacol; 1992 Jun; 106(2):409-15. PubMed ID: 1327382
[TBL] [Abstract][Full Text] [Related]
14. Receptor specificity and trigemino-vascular inhibitory actions of a novel 5-HT1B/1D receptor partial agonist, 311C90 (zolmitriptan).
Martin GR; Robertson AD; MacLennan SJ; Prentice DJ; Barrett VJ; Buckingham J; Honey AC; Giles H; Moncada S
Br J Pharmacol; 1997 May; 121(2):157-64. PubMed ID: 9154322
[TBL] [Abstract][Full Text] [Related]
15. Effects of the 5-HT1 receptor agonists, sumatriptan and CP 93,129, on dural arterial flow in the rat.
Messlinger K; Hotta H; Pawlak M; Schmidt RF
Eur J Pharmacol; 1997 Aug; 332(2):173-81. PubMed ID: 9286619
[TBL] [Abstract][Full Text] [Related]
16. Effect of a 5-HT1 receptor agonist, CP-122,288, on oedema formation induced by stimulation of the rat saphenous nerve.
Kajekar R; Gupta P; Shepperson NB; Brain SD
Br J Pharmacol; 1995 May; 115(1):1-2. PubMed ID: 7647962
[TBL] [Abstract][Full Text] [Related]
17. Agonistic properties of alniditan, sumatriptan and dihydroergotamine on human 5-HT1B and 5-HT1D receptors expressed in various mammalian cell lines.
Lesage AS; Wouters R; Van Gompel P; Heylen L; Vanhoenacker P; Haegeman G; Luyten WH; Leysen JE
Br J Pharmacol; 1998 Apr; 123(8):1655-65. PubMed ID: 9605573
[TBL] [Abstract][Full Text] [Related]
18. Neurogenic inflammation in the context of migraine.
Williamson DJ; Hargreaves RJ
Microsc Res Tech; 2001 May; 53(3):167-78. PubMed ID: 11301492
[TBL] [Abstract][Full Text] [Related]
19. 5-Hydroxytryptamine receptor agonists for the abortive treatment of vascular headaches block mast cell, endothelial and platelet activation within the rat dura mater after trigeminal stimulation.
Buzzi MG; Dimitriadou V; Theoharides TC; Moskowitz MA
Brain Res; 1992 Jun; 583(1-2):137-49. PubMed ID: 1324091
[TBL] [Abstract][Full Text] [Related]
20. Regulation of serotonin release in the frontal cortex and ventral hippocampus of homozygous mice lacking 5-HT1B receptors: in vivo microdialysis studies.
Trillat AC; Malagié I; Scearce K; Pons D; Anmella MC; Jacquot C; Hen R; Gardier AM
J Neurochem; 1997 Nov; 69(5):2019-25. PubMed ID: 9349547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
